Moderna's President Stephen Hoge stated, “As you know, and as I mentioned, there are additional Phase 3s as well as two randomized Phase 2s, including bladder cancer and renal cell carcinoma ...

with CEO Stephane Bancel taking over her sales and marketing responsibilities and President Stephen Hoge, M.D., assuming responsibility for Moderna’s pipeline commercial strategy and medical ...

Chief Legal Officer Shannon Klinger and President Stephen Hoge added to their Moderna stock holdings. In response, Moderna stock jumped nearly 16% on Monday. On Friday, shares rallied again ...

At the ongoing TD Cowen Health Care conference on Wednesday, Moderna (NASDAQ:MRNA) President Stephen Hoge noted that a late-stage trial designed to test the company's cancer shot V940 against skin ...

Moderna CEO Stéphane Bancel highlighted 2024 ... a $1 billion reduction from 2024 projections. President Stephen Hoge noted progress in pivotal studies for respiratory and non-respiratory vaccines.

Stephen Hoge was one of three kickers vying for the starting job at Kansas University. Hoge announced on Monday, August 18, that he has left the team. Stephen Hoge was one of three kickers vying ...